2
Brenntag achieved record results in financial year 2021 which was characterized by exceptional market conditions
Ein Dokument
mehr
Storys zum Thema Initial public offering
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
EANS-Adhoc: XB SYSTEMS AG SIGNS US INVESTMENT BANKING DEAL TO LIST ON NASDAQ IN 2022
issuer: XB SYSTEMS AG Eschersheimer Landstrasse 42 D-60322 Frankfurt am Main phone: +49 251 981156 7552 FAX: mail: info@xb.systems WWW: https://xb.systems/ ISIN: DE000A3H3LX7 indexes: stockmarkets: Wien language: ...
mehrEANS-News: XB Systems plans new M&A after its Listing on the Vienna Stock Exchange
issuer: XB SYSTEMS AG Eschersheimer Landstrasse 42 D-60322 Frankfurt am Main phone: +49 251 981156 7552 FAX: mail: info@xb.systems WWW: https://xb.systems/ ISIN: DE000A3H3LX7 indexes: stockmarkets: Wien language: ...
mehrBrenntag reports solid results for the second quarter of 2020
Essen (ots) - Brenntag (ISIN DE000A1DAHH0), the global market leader in chemical and ingredients distribution, reports another resilient quarter with positive operating EBITDA development and still limited impact from the COVID-19 pandemic. Christian Kohlpaintner, Chief Executive Officer of Brenntag Group, said: "Although we reported solid results in the second quarter with the COVID-19 pandemic still having limited ...
mehrAT & S Austria Technologie & Systemtechnik Aktiengesellschaft
EANS-News: AT&S is the global number one for high-end printed circuit boards
issuer: AT & S Austria Technologie & Systemtechnik Aktiengesellschaft Fabriksgasse 13 A-8700 Leoben phone: 03842 200-0 FAX: mail: ir@ats.net WWW: www.ats.net ISIN: AT0000969985 indexes: WBI, ATX GP, VÖNIX stockmarkets: Wien language: English ...
mehrEANS-Adhoc: Marinomed Biotech AG sets offer price at 75 Euro per share
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: AT0000A1WD52, ATMARINOMED6 indexes: stockmarkets: Wien language: English ...
mehrEANS-Adhoc: Marinomed Biotech AG announces strong investor demand and expected offer price
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: AT0000A1WD52 indexes: stockmarkets: Wien language: English ...
mehrEANS-Adhoc: Marinomed Biotech AG resumes offer period of the IPO
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: AT0000A1WD52, ATMARINOMED6 indexes: stockmarkets: Wien language: English ...
mehrHuge expectations by entrance into Stock Exchange Market of Investfinans Stockholm
Vällingby (ots) - Stock-market analysts eagerly expect the initial public offering, the shares are highly demanded and the total free float has already been oversubscribed more than twice fold. Preferred shareholders were given commitments of fixed dividends and a discount is planned for premarket investors. An insider from Bloomberg cited: "Such share could be the ...
mehrEANS-Adhoc: Marinomed Biotech AG suspends offer period of the current IPO
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: AT0000A1WD52, ATMARINOMED6 indexes: stockmarkets: Wien language: English ...
mehrEANS-Adhoc: Marinomed Biotech AG suspends offer period of the current IPO
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: AT0000A1WD52 indexes: stockmarkets: Wien language: English ...
mehr
1